Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease. The drugs are imatinib (marketed as Gleevec) and sunitinib (marketed as Sutent). Both were found to put type 1 diabetes into remission in 80 percent of the test mice and work permanently in 80 percent of those that go into remission.
So, should they be hailed as a new miracle treatment? I wouldn’t be so hasty. Gleevec, for example, kills heart muscle cells and can cause severe congestive heart failure. If the cure is worse than the disease, this doesn’t seem to be a great benefit.
A better way is to prevent type 1 diabetes in the first place, using natural means like vitamin D.
Physorg.com November 18, 2008